デフォルト表紙
市場調査レポート
商品コード
1478014

ダーマコスメティック市場:地域別(北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ):世界の産業分析、規模、シェア、成長、動向、2024-2031年予測

Dermacosmetics Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日: | 発行: Persistence Market Research | ページ情報: 英文 250 Pages | 納期: 2~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.53円
ダーマコスメティック市場:地域別(北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ):世界の産業分析、規模、シェア、成長、動向、2024-2031年予測
出版日: 2024年05月07日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2~5営業日
  • 全表示
  • 概要
  • 目次
概要

ダーマコスメティックの世界市場は、皮膚科学と化粧品の融合を特徴とする、より広範な美容・パーソナルケア産業の中で急成長している分野です。この市場には、美的効果を提供しながら様々な肌の悩みに対応する製品が含まれ、一般的に臨床研究に裏打ちされた有効成分が含まれています。Persistence Market Research社は、ダーマコスメティック市場力学を掘り下げ、主要な成長促進要因、課題、新興動向、競争戦略に関する考察を提供しています。この包括的な分析は、利害関係者が2024年から2031年までの市場をナビゲートするための強固な基盤を提供します。

世界のダーマコスメティック市場は、2024年から2031年にかけてCAGR 3.5%で成長し、2031年の市場規模は247億米ドルに達すると予測されます。

主な洞察

  • 推定市場価値(2024年):194億米ドル
  • 予測市場価格(2031年):247億米ドル
  • 世界市場成長率(CAGR 2024年~2031年):3.5%

ダーマコスメティック市場-レポート範囲:

ダーマコスメティクス製品は通常、治療用スキンケアと美容的魅力を融合させたもので、ニキビ、老化、色素沈着、日焼けなどの特定の肌問題をターゲットとしています。これらの製品は医療や臨床の場で販売されることが多く、皮膚科医がその有効性と安全性から推奨しています。肌の健康に対する消費者の関心が高まる中、ダーマコスメは、機能性と美容効果の両方を提供する製品へのシフトを反映し、大きな支持を得ています。

ソーシャルメディアや有名人の推薦の影響力の高まりは、市場拡大において重要な役割を果たしており、主要なオピニオンリーダーやインフルエンサーが消費者の関心を促進しています。さらに、非侵襲的なスキンケアソリューションに対する需要の高まりは、外科的手術や集中的な皮膚科的処置に代わるものを消費者が求めていることから、ダーマコスメティックの成長を後押ししています。

市場成長の促進要因:

ダーマコスメティック市場の成長を促進する要因はいくつかあります。スキンケアと個人の健康への関心の高まりが、効果的で臨床的裏付けのある製品に対する消費者の需要を促進しています。eコマース・プラットフォームや消費者直販チャネルの拡大により、製品へのアクセスが向上し、市場成長に寄与しています。

さらに、世界人口の高齢化と皮膚関連疾患の増加が、専門的なスキンケアソリューションの必要性を高めています。ダーマコスメティック企業は製品のイノベーションに注力し、消費者の多様な嗜好にアピールしながら、幅広い肌悩みに対応する処方を開発しています。また、消費者が効果的で環境に配慮した製品を求めているため、クリーンでナチュラルな成分を求める傾向が強まっていることも、市場成長の原動力となっています。

市場の抑制要因:

堅調な成長が見込まれるもの、ダーマコスメティック市場は課題に直面しています。研究開発コストが高いことに加え、有効成分を含む製品に対する規制要件が厳しいため、中小企業の市場参入が制限される可能性があります。さらに、臨床的検証や皮膚科学的お墨付きが必要なことも、新製品発売の障壁となっています。

製品の謳い文句に対する消費者の懐疑的な見方や、マーケティングにおける透明性の欠如も市場成長の妨げとなります。偽造品や規制対象外の製品が市場に蔓延していることは、消費者の信頼を損ない、正規のダーマコスメティック・ブランドの売上に影響を与えています。

市場機会:

ダーマコスメティック市場には、拡大・革新の機会が数多くあります。個々の肌タイプや悩みに合わせた製品を提供するパーソナライズド・スキンケアの台頭は、大きな成長分野です。AIを活用した肌分析やデジタルコンサルテーションなどの技術進歩により、企業はカスタマイズされたソリューションを提供できるようになり、消費者の満足度を高めています。

ダーマコスメティック企業と皮膚科医や医療専門家とのコラボレーションは、より効果的な製品の開発につながり、消費者の信頼を高める。さらに、スキンケアへの意識が高まっている新興市場への進出は、大きな成長機会となります。

本レポートで扱う主な質問

  • 2024年から2031年までのダーマコスメティック市場の予想CAGRは?
  • ダーマコスメティック市場の主要成長促進要因は何か?
  • ダーマコスメティック市場で最大の市場シェアを占める地域はどこか?
  • ダーマコスメティックの世界市場における主要プレイヤーは?
  • ダーマコスメティック市場における主な課題とビジネスチャンスは?

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類
  • 市場の定義/範囲/制限
  • 包含・除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 重要成功要因

  • 製品採用分析
  • 皮膚疾患疫学
  • 最近の製品の発売と承認
  • 規制シナリオ
  • PESTLE分析
  • ポーター分析
  • サプライチェーン分析
  • メーカーが採用した主要戦略

第5章 市場背景

  • マクロ経済要因
  • 予測要因-関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 治療別収益
    • 適応症別収益
    • 流通チャネル別収益
    • 国別収益
  • 2024年の市場シナリオ

第7章 ダーマコスメティック市場の需要(金額および規模)分析

  • 過去の市場(金額)分析、2019-2023年
  • 現在および将来の市場(金額)予測、2024~2031年

第8章 ダーマコスメティック市場分析、治療別

  • イントロダクション/主な調査結果
  • 過去の市場規模(金額)の分析、2019-2023年
  • 現在および将来の市場規模(金額)の分析と予測、2024-2031年
    • スキンケア
    • ヘアケア
    • 老化防止
    • 衛生
    • サンケア
    • 化粧品
    • フェイシャルケア
    • その他
  • 治療別の市場魅力度分析

第9章 ダーマコスメティック市場分析、適応症別

  • イントロダクション/主な調査結果
  • 過去の市場規模(金額)分析、2019-2023年
  • 現在および将来の市場規模(金額)分析と予測、2024-2031年
    • 乾燥肌
    • アトピー性皮膚湿疹
    • 色素沈着
    • 傷跡とニキビ
    • 乾癬
    • 深いシワ
    • その他
  • 適応症別の市場魅力度分析

第10章 ダーマコスメティック市場分析、流通チャネル別

  • イントロダクション/主な調査結果
  • 過去の市場規模(金額)分析、2019-2023年
  • 現在および将来の市場規模(金額)分析と予測、2024-2031年
    • 病院薬局
    • 小売薬局
    • eコマースストア
    • ハイパーマーケットとスーパーマーケット
    • 専門クリニック
  • 流通チャネル別市場魅力度分析

第11章 ダーマコスメティック市場分析、地域別

  • イントロダクション
  • 過去の市場規模(金額)分析、2019-2023年
  • 現在および将来の市場規模(金額)分析と予測、2024-2031年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東およびアフリカ(MEA)
  • 地域別市場魅力度分析

第12章 北米のダーマコスメティック市場分析

第13章 ラテンアメリカのダーマコスメティック市場分析

第14章 欧州のダーマコスメティック市場分析

第15章 南アジアのダーマコスメティック市場分析

第16章 東アジアのダーマコスメティック市場分析

第17章 オセアニアダーマコスメティック市場分析

第18章 中東およびアフリカ(MEA)ダーマコスメティック市場分析

第19章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場集中
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Merck KGaA
    • Oxytical
    • L'Oreal Group
    • Cipla Inc.
    • Pierre Fabre group
    • Johnson &Johnson
    • NAOS
    • Puig
    • Swisskem Healthcare.
    • Kuora Dermo Cosmetics
    • Politech
    • CeraVe
    • GALDERMA LABORATORIES, LP
    • BEIERSDORF
    • Bausch Health Companies Inc.
    • Ultimate Skin Aesthetics GmbH
    • Procter &Gamble
    • Unilever
    • Coty
    • Colgate-Palmolive

第21章 使用される前提条件と頭字語

第22章 調査手法

目次
Product Code: PMRREP33162

The global dermacosmetics market is a rapidly growing sector within the broader beauty and personal care industry, characterized by the convergence of dermatology and cosmetics. This market encompasses products that address various skin concerns while providing aesthetic benefits, typically containing active ingredients backed by clinical research. Persistence Market Research delves into the dynamics of the dermacosmetics market, offering insights into key growth drivers, challenges, emerging trends, and competitive strategies. This comprehensive analysis provides a robust foundation for stakeholders to navigate the market from 2024 to 2031.

The global dermacosmetics market is expected to grow at a CAGR of 3.5% from 2024 to 2031, with a projected market size of USD 24.7 billion by 2031.

Key Insights:

  • Estimated Market Value (2024): USD 19.4 Billion
  • Projected Market Value (2031): USD 24.7 Billion
  • Global Market Growth Rate (CAGR 2024 to 2031): 3.5%

Dermacosmetics Market - Report Scope:

Dermacosmetics products typically blend therapeutic skincare with aesthetic appeal, targeting specific skin issues such as acne, aging, pigmentation, and sun damage. These products are often sold in medical or clinical settings, with dermatologists recommending them for their efficacy and safety. With the growing consumer interest in skin health, dermacosmetics have gained significant traction, reflecting a shift toward products that offer both functional and cosmetic benefits.

The growing influence of social media and celebrity endorsements plays a significant role in market expansion, with key opinion leaders and influencers driving consumer interest. Furthermore, the rising demand for non-invasive skincare solutions propels the growth of dermacosmetics, with consumers seeking alternatives to surgical or intensive dermatological procedures.

Market Growth Drivers:

Several factors drive the growth of the dermacosmetics market. An increasing focus on skincare and personal well-being fuels consumer demand for effective, clinically-backed products. The expansion of e-commerce platforms and direct-to-consumer sales channels has improved product accessibility, contributing to market growth.

In addition, the aging global population and the rise in skin-related disorders increase the need for specialized skincare solutions. Dermacosmetics companies focus on product innovation, developing formulations that address a wide range of skin concerns while appealing to diverse consumer preferences. The growing trend towards clean and natural ingredients also drives market growth, as consumers seek products that are both effective and environmentally conscious.

Market Restraints:

Despite robust growth prospects, the dermacosmetics market faces challenges. The high cost of research and development, coupled with stringent regulatory requirements for products containing active ingredients, can limit market entry for smaller players. Additionally, the need for clinical validation and dermatological endorsements poses a barrier to new product launches.

Consumer skepticism regarding product claims and a lack of transparency in marketing can also hinder market growth. The growing prevalence of counterfeit and unregulated products in the market undermines consumer trust, impacting the sales of legitimate dermacosmetics brands.

Market Opportunities:

The dermacosmetics market offers numerous opportunities for expansion and innovation. The rise of personalized skincare, with products tailored to individual skin types and concerns, represents a significant growth area. Technological advancements, such as AI-based skin analysis and digital consultations, allow companies to offer customized solutions, enhancing consumer satisfaction.

Collaborations between dermacosmetics companies and dermatologists or medical professionals can lead to the development of more effective products and increase consumer trust. Moreover, expanding into emerging markets, where skincare awareness is rising, presents a significant growth opportunity.

Key Questions Addressed in the Report:

  • What is the Expected CAGR of the Dermacosmetics Market from 2024 to 2031?
  • What are the Key Growth Drivers for the Dermacosmetics Market?
  • Which Region Holds the Largest Market Share in the Dermacosmetics Market?
  • Who are the Key Players in the Global Dermacosmetics Market?
  • What Are the Main Challenges and Opportunities in the Dermacosmetics Market?

Competitive Landscape and Business Strategies:

The competitive landscape of the dermacosmetics market features both established companies and emerging players. Leading firms like L'Oreal, Estee Lauder, and Johnson & Johnson focus on innovation and strategic acquisitions to strengthen their market position. Partnerships with dermatologists and healthcare professionals are common strategies to boost credibility and product endorsement.

Companies also invest in extensive marketing campaigns and collaborations with social media influencers to reach a wider audience. Sustainability and ethical sourcing are becoming increasingly important, with companies adopting eco-friendly practices and emphasizing clean ingredient formulations to meet consumer expectations.

Key Companies Profiled:

  • L'Oreal S.A.
  • Estee Lauder Companies Inc.
  • Johnson & Johnson
  • Procter & Gamble Co.
  • Unilever
  • Shiseido Company, Limited
  • Beiersdorf AG
  • Amorepacific Corporation
  • Pierre Fabre Group
  • Galderma Laboratories, L.P.

Dermacosmetics Market Segmentation:

By Treatment:

  • Skin Care
  • Hair Care
  • Anti-aging
  • Hygiene
  • Sun Care
  • Cosmetics
  • Facial care
  • Others

By Indication:

  • Dry Skin
  • Atopic Skin Eczema
  • Hyperpigmentation
  • Scar & Acne
  • Psoriasis
  • Deep Wrinkles
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce stores
  • Hypermarkets & Supermarkets
  • Speciality Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Skin Diseases Epidemiology
  • 4.3. Recent Product Launches and Approvals
  • 4.4. Regulatory Scenario
  • 4.5. PESTLE Analysis
  • 4.6. Porters Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Key Strategies Adopted By Manufacturers

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Cosmetics Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Pharmaceutical and Biotechnology R&D Expenditure
    • 5.2.2. Custom Products Offerings for Specific Needs
    • 5.2.3. Increasing Preventives of Specific Skin Conditions
    • 5.2.4. Availability of a Range of Skincare Products
    • 5.2.5. Increasing Commercialization of Novel Products
    • 5.2.6. Key Regulation Policies
    • 5.2.7. Strategic Mergers and Acquisitions Among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue By Treatment
    • 6.1.2. Revenue By Indication
    • 6.1.3. Revenue By Distribution Channel
    • 6.1.4. Revenue By Country
  • 6.2. 2024 Market Scenario

7. Dermacosmetics Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031, by Treatment

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Treatment, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment, 2024-2031
    • 8.3.1. Skin Care
    • 8.3.2. Hair Care
    • 8.3.3. Anti-Aging
    • 8.3.4. Hygiene
    • 8.3.5. Sun Care
    • 8.3.6. Cosmetics
    • 8.3.7. Facial Care
    • 8.3.8. Others
  • 8.4. Market Attractiveness Analysis By Treatment

9. Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031, by Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2024-2031
    • 9.3.1. Dry Skin
    • 9.3.2. Atopic Skin Eczema
    • 9.3.3. Hyperpigmentation
    • 9.3.4. Scar & Acne
    • 9.3.5. Psoriasis
    • 9.3.6. Deep Wrinkles
    • 9.3.7. Others
  • 9.4. Market Attractiveness Analysis By Indication

10. Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031, by Distribution Channel

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2031
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. E-commerce stores
    • 10.3.4. Hypermarkets & supermarkets
    • 10.3.5. Speciality Clinics
  • 10.4. Market Attractiveness Analysis By Distribution Channel

11. Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Treatment
    • 12.3.3. By Indication
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Treatment
    • 12.4.3. By Indication
    • 12.4.4. By Distribution Channel
  • 12.5. Key Market Participants - Intensity Mapping
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Market Trends
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Dermacosmetics Market
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Treatment
        • 12.8.1.2.2. By Indication
        • 12.8.1.2.3. By Distribution Channel
    • 12.8.2. Canada Dermacosmetics Market
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Treatment
        • 12.8.2.2.2. By Indication
        • 12.8.2.2.3. By Distribution Channel

13. Latin America Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Treatment
    • 13.3.3. By Indication
    • 13.3.4. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Treatment
    • 13.4.3. By Indication
    • 13.4.4. By Distribution Channel
  • 13.5. Key Market Participants - Intensity Mapping
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Market Trends
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Brazil Dermacosmetics Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Treatment
        • 13.8.1.2.2. By Indication
        • 13.8.1.2.3. By Distribution Channel
    • 13.8.2. Mexico Dermacosmetics Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Treatment
        • 13.8.2.2.2. By Indication
        • 13.8.2.2.3. By Distribution Channel
    • 13.8.3. Argentina Dermacosmetics Market
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Treatment
        • 13.8.3.2.2. By Indication
        • 13.8.3.2.3. By Distribution Channel

14. Europe Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Nordic Countries
      • 14.3.1.8. Russia
      • 14.3.1.9. Rest of Europe
    • 14.3.2. By Treatment
    • 14.3.3. By Indication
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Treatment
    • 14.4.3. By Indication
    • 14.4.4. By Distribution Channel
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Market Trends
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Germany Dermacosmetics Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Treatment
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By Distribution Channel
    • 14.8.2. France Dermacosmetics Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Treatment
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By Distribution Channel
    • 14.8.3. Italy Dermacosmetics Market
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Treatment
        • 14.8.3.2.2. By Indication
        • 14.8.3.2.3. By Distribution Channel
    • 14.8.4. Spain Dermacosmetics Market
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.4.2.1. By Treatment
        • 14.8.4.2.2. By Indication
        • 14.8.4.2.3. By Distribution Channel
    • 14.8.5. U.K. Dermacosmetics Market
      • 14.8.5.1. Introduction
      • 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.5.2.1. By Treatment
        • 14.8.5.2.2. By Indication
        • 14.8.5.2.3. By Distribution Channel
    • 14.8.6. Benelux Union Dermacosmetics Market
      • 14.8.6.1. Introduction
      • 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.6.2.1. By Treatment
        • 14.8.6.2.2. By Indication
        • 14.8.6.2.3. By Distribution Channel
    • 14.8.7. Nordic Countries Dermacosmetics Market
      • 14.8.7.1. Introduction
      • 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.7.2.1. By Treatment
        • 14.8.7.2.2. By Indication
        • 14.8.7.2.3. By Distribution Channel
    • 14.8.8. Russia Dermacosmetics Market
      • 14.8.8.1. Introduction
      • 14.8.8.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.8.2.1. By Treatment
        • 14.8.8.2.2. By Indication
        • 14.8.8.2.3. By Distribution Channel

15. South Asia Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Treatment
    • 15.3.3. By Indication
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Treatment
    • 15.4.3. By Indication
    • 15.4.4. By Distribution Channel
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Market Trends
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. India Dermacosmetics Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Treatment
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By Distribution Channel
    • 15.8.2. Indonesia Dermacosmetics Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Treatment
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By Distribution Channel
    • 15.8.3. Malaysia Dermacosmetics Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Treatment
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. By Distribution Channel
    • 15.8.4. Thailand Dermacosmetics Market
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Treatment
        • 15.8.4.2.2. By Indication
        • 15.8.4.2.3. By Distribution Channel

16. East Asia Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Treatment
    • 16.3.3. By Indication
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Treatment
    • 16.4.3. By Indication
    • 16.4.4. By Distribution Channel
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Market Trends
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China Dermacosmetics Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Treatment
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By Distribution Channel
    • 16.8.2. Japan Dermacosmetics Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Treatment
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By Distribution Channel
    • 16.8.3. South Korea Dermacosmetics Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Treatment
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By Distribution Channel

17. Oceania Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Treatment
    • 17.3.3. By Indication
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Treatment
    • 17.4.3. By Indication
    • 17.4.4. By Distribution Channel
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Market Trends
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Australia Dermacosmetics Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Treatment
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By Distribution Channel
    • 17.8.2. New Zealand Dermacosmetics Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Treatment
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. North Africa
      • 18.3.1.4. South Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Treatment
    • 18.3.3. By Indication
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Treatment
    • 18.4.3. By Indication
    • 18.4.4. By Distribution Channel
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Market Trends
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. GCC Countries Dermacosmetics Market
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Treatment
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By Distribution Channel
    • 18.8.2. Turkey Dermacosmetics Market
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Treatment
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By Distribution Channel
    • 18.8.3. North Africa Dermacosmetics Market
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Treatment
        • 18.8.3.2.2. By Indication
        • 18.8.3.2.3. By Distribution Channel
    • 18.8.4. South Africa Dermacosmetics Market
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Treatment
        • 18.8.4.2.2. By Indication
        • 18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Concentration
  • 19.4. Market Presence Analysis
    • 19.4.1. Regional Footprint Analysis
    • 19.4.2. Treatment Footprint Analysis
    • 19.4.3. Channel Footprint Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Merck KGaA
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Key Financials
      • 20.3.1.4. SWOT Analysis
      • 20.3.1.5. Sales Footprint
      • 20.3.1.6. Strategy Overview
      • 20.3.1.7. Key Developments
        • 20.3.1.7.1. Marketing Strategies
        • 20.3.1.7.2. Product Strategies
        • 20.3.1.7.3. Channel Strategies
    • 20.3.2. Oxytical
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Key Financials
      • 20.3.2.4. SWOT Analysis
      • 20.3.2.5. Sales Footprint
      • 20.3.2.6. Strategy Overview
      • 20.3.2.7. Key Developments
        • 20.3.2.7.1. Marketing Strategies
        • 20.3.2.7.2. Product Strategies
        • 20.3.2.7.3. Channel Strategies
    • 20.3.3. L'Oreal Group
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Key Financials
      • 20.3.3.4. SWOT Analysis
      • 20.3.3.5. Sales Footprint
      • 20.3.3.6. Strategy Overview
      • 20.3.3.7. Key Developments
        • 20.3.3.7.1. Marketing Strategies
        • 20.3.3.7.2. Product Strategies
        • 20.3.3.7.3. Channel Strategies
    • 20.3.4. Cipla Inc.
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Key Financials
      • 20.3.4.4. SWOT Analysis
      • 20.3.4.5. Sales Footprint
      • 20.3.4.6. Strategy Overview
      • 20.3.4.7. Key Developments
        • 20.3.4.7.1. Marketing Strategies
        • 20.3.4.7.2. Product Strategies
        • 20.3.4.7.3. Channel Strategies
    • 20.3.5. Pierre Fabre group
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Key Financials
      • 20.3.5.4. SWOT Analysis
      • 20.3.5.5. Sales Footprint
      • 20.3.5.6. Strategy Overview
      • 20.3.5.7. Key Developments
        • 20.3.5.7.1. Marketing Strategies
        • 20.3.5.7.2. Product Strategies
        • 20.3.5.7.3. Channel Strategies
    • 20.3.6. Johnson & Johnson
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Key Financials
      • 20.3.6.4. SWOT Analysis
      • 20.3.6.5. Sales Footprint
      • 20.3.6.6. Strategy Overview
      • 20.3.6.7. Key Developments
        • 20.3.6.7.1. Marketing Strategies
        • 20.3.6.7.2. Product Strategies
        • 20.3.6.7.3. Channel Strategies
    • 20.3.7. NAOS
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Key Financials
      • 20.3.7.4. SWOT Analysis
      • 20.3.7.5. Sales Footprint
      • 20.3.7.6. Strategy Overview
      • 20.3.7.7. Key Developments
        • 20.3.7.7.1. Marketing Strategies
        • 20.3.7.7.2. Product Strategies
        • 20.3.7.7.3. Channel Strategies
    • 20.3.8. Puig
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Key Financials
      • 20.3.8.4. SWOT Analysis
      • 20.3.8.5. Sales Footprint
      • 20.3.8.6. Strategy Overview
      • 20.3.8.7. Key Developments
        • 20.3.8.7.1. Marketing Strategies
        • 20.3.8.7.2. Product Strategies
        • 20.3.8.7.3. Channel Strategies
    • 20.3.9. Swisskem Healthcare.
      • 20.3.9.1. Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Key Financials
      • 20.3.9.4. SWOT Analysis
      • 20.3.9.5. Sales Footprint
      • 20.3.9.6. Strategy Overview
      • 20.3.9.7. Key Developments
        • 20.3.9.7.1. Marketing Strategies
        • 20.3.9.7.2. Product Strategies
        • 20.3.9.7.3. Channel Strategies
    • 20.3.10. Kuora Dermo Cosmetics
      • 20.3.10.1. Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Key Financials
      • 20.3.10.4. SWOT Analysis
      • 20.3.10.5. Sales Footprint
      • 20.3.10.6. Strategy Overview
      • 20.3.10.7. Key Developments
        • 20.3.10.7.1. Marketing Strategies
        • 20.3.10.7.2. Product Strategies
        • 20.3.10.7.3. Channel Strategies
    • 20.3.11. Politech
      • 20.3.11.1. Overview
      • 20.3.11.2. Product Portfolio
      • 20.3.11.3. Key Financials
      • 20.3.11.4. SWOT Analysis
      • 20.3.11.5. Sales Footprint
      • 20.3.11.6. Strategy Overview
      • 20.3.11.7. Key Developments
        • 20.3.11.7.1. Marketing Strategies
        • 20.3.11.7.2. Product Strategies
        • 20.3.11.7.3. Channel Strategies
    • 20.3.12. CeraVe
      • 20.3.12.1. Overview
      • 20.3.12.2. Product Portfolio
      • 20.3.12.3. Key Financials
      • 20.3.12.4. SWOT Analysis
      • 20.3.12.5. Sales Footprint
      • 20.3.12.6. Strategy Overview
      • 20.3.12.7. Key Developments
        • 20.3.12.7.1. Marketing Strategies
        • 20.3.12.7.2. Product Strategies
        • 20.3.12.7.3. Channel Strategies
    • 20.3.13. GALDERMA LABORATORIES, L.P.
      • 20.3.13.1. Overview
      • 20.3.13.2. Product Portfolio
      • 20.3.13.3. Key Financials
      • 20.3.13.4. SWOT Analysis
      • 20.3.13.5. Sales Footprint
      • 20.3.13.6. Strategy Overview
      • 20.3.13.7. Key Developments
        • 20.3.13.7.1. Marketing Strategies
        • 20.3.13.7.2. Product Strategies
        • 20.3.13.7.3. Channel Strategies
    • 20.3.14. BEIERSDORF
      • 20.3.14.1. Overview
      • 20.3.14.2. Product Portfolio
      • 20.3.14.3. Key Financials
      • 20.3.14.4. SWOT Analysis
      • 20.3.14.5. Sales Footprint
      • 20.3.14.6. Strategy Overview
      • 20.3.14.7. Key Developments
        • 20.3.14.7.1. Marketing Strategies
        • 20.3.14.7.2. Product Strategies
        • 20.3.14.7.3. Channel Strategies
    • 20.3.15. Bausch Health Companies Inc.
      • 20.3.15.1. Overview
      • 20.3.15.2. Product Portfolio
      • 20.3.15.3. Key Financials
      • 20.3.15.4. SWOT Analysis
      • 20.3.15.5. Sales Footprint
      • 20.3.15.6. Strategy Overview
      • 20.3.15.7. Key Developments
        • 20.3.15.7.1. Marketing Strategies
        • 20.3.15.7.2. Product Strategies
        • 20.3.15.7.3. Channel Strategies
    • 20.3.16. Ultimate Skin Aesthetics GmbH
      • 20.3.16.1. Overview
      • 20.3.16.2. Product Portfolio
      • 20.3.16.3. Key Financials
      • 20.3.16.4. SWOT Analysis
      • 20.3.16.5. Sales Footprint
      • 20.3.16.6. Strategy Overview
      • 20.3.16.7. Key Developments
        • 20.3.16.7.1. Marketing Strategies
        • 20.3.16.7.2. Product Strategies
        • 20.3.16.7.3. Channel Strategies
    • 20.3.17. Procter & Gamble
      • 20.3.17.1. Overview
      • 20.3.17.2. Product Portfolio
      • 20.3.17.3. Key Financials
      • 20.3.17.4. SWOT Analysis
      • 20.3.17.5. Sales Footprint
      • 20.3.17.6. Strategy Overview
      • 20.3.17.7. Key Developments
        • 20.3.17.7.1. Marketing Strategies
        • 20.3.17.7.2. Product Strategies
        • 20.3.17.7.3. Channel Strategies
    • 20.3.18. Unilever
      • 20.3.18.1. Overview
      • 20.3.18.2. Product Portfolio
      • 20.3.18.3. Key Financials
      • 20.3.18.4. SWOT Analysis
      • 20.3.18.5. Sales Footprint
      • 20.3.18.6. Strategy Overview
      • 20.3.18.7. Key Developments
        • 20.3.18.7.1. Marketing Strategies
        • 20.3.18.7.2. Product Strategies
        • 20.3.18.7.3. Channel Strategies
    • 20.3.19. Coty
      • 20.3.19.1. Overview
      • 20.3.19.2. Product Portfolio
      • 20.3.19.3. Key Financials
      • 20.3.19.4. SWOT Analysis
      • 20.3.19.5. Sales Footprint
      • 20.3.19.6. Strategy Overview
      • 20.3.19.7. Key Developments
        • 20.3.19.7.1. Marketing Strategies
        • 20.3.19.7.2. Product Strategies
        • 20.3.19.7.3. Channel Strategies
    • 20.3.20. Colgate-Palmolive
      • 20.3.20.1. Overview
      • 20.3.20.2. Product Portfolio
      • 20.3.20.3. Key Financials
      • 20.3.20.4. SWOT Analysis
      • 20.3.20.5. Sales Footprint
      • 20.3.20.6. Strategy Overview
      • 20.3.20.7. Key Developments
        • 20.3.20.7.1. Marketing Strategies
        • 20.3.20.7.2. Product Strategies
        • 20.3.20.7.3. Channel Strategies

21. Assumptions and Acronyms Used

22. Research Methodology